ID   ML46
AC   CVCL_DG82
DR   Wikidata; Q54905941
RX   PubMed=17519898;
RX   PubMed=23415752;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4511; Ovarian serous cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
RX   PubMed=23415752; DOI=10.1016/j.molonc.2012.12.007; PMCID=PMC4106023;
RA   Stordal, Britta
RA   Timms, Kirsten
RA   Farrelly, Angela
RA   Gallagher, Danielle
RA   Busschots, Steven
RA   Renaud, Mickael
RA   Thery, Julien
RA   Williams, Deborah
RA   Potter, Jennifer
RA   Tran, Thanh
RA   Korpanty, Greg
RA   Cremona, Mattia
RA   Carey, Mark S.
RA   Li, Jie
RA   Li, Yang
RA   Aslan, Ozlem
RA   O'Leary, John J.
RA   Mills, Gordon B.
RA   Hennessy, Bryan T.
RT   "BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one
RT   functionally deleterious BRCA1 mutation.";
RL   Mol. Oncol. 7:567-579(2013).
//
RX   PubMed=17519898; DOI=10.1038/sj.bjc.6603817; PMCID=PMC2359981;
RA   Yu, Jia-Mei
RA   Roy, Deodutta
RA   Brockmeyer, Amy Dawn
RA   Dubeau, Louis
RT   "Increased chromosomal stability in cultures of ovarian tumours of low
RT   malignant potential compared to cystadenomas.";
RL   Br. J. Cancer 96:1908-1913(2007).
//